PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder Tumors
NCT01567462 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 95
Last updated 2017-12-08
Summary
The purpose of this study is to compare the use of two types of equipment during transurethral resection of bladder tumors (TURBT). The two types of surgical devices are: the monopolar loop electrocautery and the PlasmaKinetic (PK) Button Vaporization Electrode. These two devices do the same task but differ in the way they create electric current when removing cancerous tissue. The investigators hope to examine and compare the uses of these two surgical devices to see if any advantages do exist or whether they actually are similar. The goal of the study is to prove similarity in outcomes between the two techniques and analyze the outcomes resulting from each case.
Conditions
Interventions
- DEVICE
-
Monopolar electrocautery loop in Transurethral resection of bladder tumors
Standard monopolar electrocautery loop in transurethral resection of bladder tumors (TURBT)
- DEVICE
-
PK Button Vaporization Electrode in transurethral resection of bladder tumors
PlasmaKinetic (PK) Button Vaporization Electrode in transurethral resection of bladder tumors (TURBT)
Sponsors & Collaborators
-
Olympus
collaborator INDUSTRY -
Emory University
lead OTHER
Principal Investigators
-
Kenneth Ogan, MD · Emory University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 89 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-09-30
- Primary Completion
- 2017-03-28
- Completion
- 2017-03-28
Countries
- United States
Study Locations
More Related Trials
-
Study of CG0070 Given in Combination With Pembrolizumab, in Non-Muscle Invasive Bladder Cancer, Unresponsive to Bacillus Calmette-Guerin
NCT04387461 ·Status: COMPLETED ·Phase: PHASE2
-
Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support
NCT07048496 ·Status: RECRUITING ·Phase: NA
-
Pembrolizumab and BCG Solution in Treating Patients With Recurrent Non-Muscle-Invasive Bladder Cancer
NCT02808143 ·Status: COMPLETED ·Phase: PHASE1
-
Pembrolizumab (MK-3475) and Bacillus Calmette-Guérin (BCG) as First-Line Treatment for High-Risk T1 Non-Muscle-Invasive Bladder Cancer (NMIBC) and High-Grade Non-Muscle-Invasive Upper Tract Urothelial Carcinoma (NMI-UTUC)]
NCT03504163 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood
NCT04811846 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005)
NCT06305767 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
NCT04235764 ·Status: RECRUITING
-
Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma
NCT04701918 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Comparing Effects of Thulium Laser en Bloc Resection and Electrical Transurethral Resection of the Non-muscle Invasive Bladder Cancer
NCT02951078 ·Status: UNKNOWN ·Phase: PHASE3
-
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
NCT00777491 ·Status: COMPLETED ·Phase: PHASE2
-
Vascularized Composite Bladder Allograft Transplantation
NCT05462561 ·Status: RECRUITING ·Phase: NA
-
TURBt With Adjuvant Cryoablation to Treat Bladder Cancer
NCT02760953 ·Status: UNKNOWN ·Phase: NA
-
En-Bloc Resection of Bladder Tumors
NCT04784507 ·Status: UNKNOWN ·Phase: PHASE2
-
Bladder PREserVation by RadioTherapy and Immunotherapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer
NCT03950362 ·Status: UNKNOWN ·Phase: PHASE2
-
Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer
NCT02716961 ·Status: UNKNOWN ·Phase: NA
-
Safety Study of Bipolar Versus Monopolar Transurethral Resection of Bladder Tumors
NCT01446822 ·Status: COMPLETED ·Phase: NA
-
Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer
NCT05239624 ·Status: RECRUITING ·Phase: PHASE2
-
Intravesical Adjuvant Electromotive Mitomycin-C
NCT01920269 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Adjuvant Radiation for High Risk Bladder Cancer
NCT01954173 ·Status: TERMINATED ·Phase: NA
-
Hyperthermic Intravesical Perfusion for Muscle-invasive Bladder Urothelial Carcinoma
NCT05276167 ·Status: RECRUITING ·Phase: NA
-
Bipolar Enbloc Versus Thulium-Yag Enbloc Resection of Bladder Tumors
NCT06119724 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Comparison Study of Narrow Band Imaging Versus White Light Resection in Patients With Bladder Tumors/Cancer
NCT01180478 ·Status: COMPLETED ·Phase: NA
-
Development and Validation of a Simulator-based Test in Transurethral Resection of Bladder Tumors
NCT03863028 ·Status: COMPLETED
-
A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer
NCT02138734 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Intravesical Electromotive Mitomycin After Bacillus Calmette-Guérin Failure
NCT04311580 ·Status: COMPLETED ·Phase: PHASE2